{"id":2170654,"date":"2022-05-17T20:25:00","date_gmt":"2022-05-17T18:25:00","guid":{"rendered":"http:\/\/nhub.news\/?p=2170654"},"modified":"2022-05-18T03:40:24","modified_gmt":"2022-05-18T01:40:24","slug":"us-regulators-authorize-pfizer-covid-19-booster-for-children-as-young-as-5","status":"publish","type":"post","link":"http:\/\/nhub.news\/ru\/2022\/05\/us-regulators-authorize-pfizer-covid-19-booster-for-children-as-young-as-5\/","title":{"rendered":"US Regulators Authorize Pfizer COVID-19 Booster for Children as Young as 5"},"content":{"rendered":"<p style=\"text-align: justify;\"><b>Americans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded \u2026<\/b><br \/>\nAmericans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded emergency authorization for Pfizer\u2019s shot. The regulatory agency expanded clearance of a third Pfizer shot to children aged 5 to 11 at least five months after their second dose. The extra shot is needed because of waning protection from the primary series, which is two doses, Dr. Peter Marks, head of the FDA\u2019s Center for Biologics Evaluation and Research, said in a statement. The data underpinning the move comes from just 67 children, who are part of Pfizer\u2019s ongoing trial evaluating the vaccine it made with Germany\u2019s BioNTech. Antibody responses were evaluated in the kids, all of whom received a third dose seven to nine months after getting a second dose. The level of antibodies against the virus that causes COVID-19 \u201cwas increased\u201d compared to before getting the booster dose, according to the FDA. All of the kids received a third dose seven to nine months after getting a second dose. Safety data from a group of about 400 children between the ages of 5 to 11 who received a booster also supported the authorization. The data has not been peer reviewed or otherwise published in full since being outlined in a press release from Pfizer and BioNTech in April. The vaccine for all age groups has proven less effective against Omicron, the strain of the CCP (Chinese Communist Party) virus that became dominant in the United States in late 2021. The CCP virus, also known as SARS-CoV-2, causes COVID-19. The emergency authorization for Pfizer\u2019s shot is for the prevention of COVID-19. Regulators authorized Pfizer\u2019s primary series for kids aged 5 to 11 in the fall of 2021. Since then, approximately 10 million have received at least one dose. Authorities are still pushing vaccination, asserting that the protection against severe illness outweighs the vaccine\u2019s risks, including heart inflammation.<br \/>\u201cVaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe,\u201d Dr. Robert Califf, the FDA\u2019s commissioner, said in a statement. In clearing the shot for children as young as 5, the FDA continued a growing trend of not asking its panel of expert advisers whether it should grant or reject Pfizer\u2019s request for authorization.<br \/>\u201cWhere is the transparent process the public was promised? Once again, the FDA rubber stamped without holding an Advisory Committee and an opportunity to hear discussion and rationale,\u201d Kim Witczak, co-founder of the drug safety group Woody Matters, told The Epoch Times in an email. \u201cYet another decision with major safety consequences made behind closed doors. Our children are not guinea pigs.\u201d<br \/> Multiple members of the panel previously questioned whether the vaccine from Pfizer should be given to all children. After three studies showed the effectiveness of the shot was worse than originally stated, Dr. Cody Meissner, one of the members, told The Epoch Times that the benefit of the vaccine \u201croughly equals the risk of harm\u201d for most kids. The Centers for Disease Control and Prevention is convening its panel on May 19 to discuss COVID-19 vaccine booster doses. The FDA decides whether vaccines should be authorized for certain age groups and the CDC decides which people in those groups can get the shots. The CDC could restrict the booster to certain kids, such as those with weakened immune systems.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Americans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded \u2026 Americans as young as 5 can get a COVID-19 vaccine booster after the U.S. Food and Drug Administration (FDA) on May 17 expanded emergency authorization for Pfizer\u2019s shot. The regulatory agency [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2170653,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[105],"tags":[],"_links":{"self":[{"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/posts\/2170654"}],"collection":[{"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/comments?post=2170654"}],"version-history":[{"count":0,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/posts\/2170654\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/media\/2170653"}],"wp:attachment":[{"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/media?parent=2170654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/categories?post=2170654"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/nhub.news\/ru\/wp-json\/wp\/v2\/tags?post=2170654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}